China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of factors influencing infliximab efficacy for Crohn's disease and construction and validation of precision pharmaceutical monitoring pathways'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133879
Registration Time: 2026/10/09
Type: Interventional study
Primary Sponsor: Shanghai Baoshan District Dachang Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343225
Published by HT Digital Content Services with permission from Health Daily Digest....